It may (or may not) surprise to learn that hypoactive sexual desire disorder (HSDD) the “disorder” treated by the new drug Addyi didn’t exist before 2004. Why in 2004 did we decide that normal female sexual response was a condition? Well, HSDD was established/invented/introduced by industry to prepare the market for a testosterone patch for …
Continue reading “How Medscape helped Sprout stack the deck for Addyi”